---
title: "BIOLASE, Inc. (BIOLQ.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/BIOLQ.US.md"
symbol: "BIOLQ.US"
name: "BIOLASE, Inc."
industry: "Health Care Equipment"
datetime: "2026-05-21T22:32:23.687Z"
locales:
  - [en](https://longbridge.com/en/quote/BIOLQ.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/BIOLQ.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/BIOLQ.US.md)
---

# BIOLASE, Inc. (BIOLQ.US)

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | US Market |
| Website | [www.biolase.com](https://www.biolase.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-21T04:30:18.000Z

**Overall: C (0.52)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 122 / 183 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -7.44% |  |
| Net Profit YoY | 62.12% |  |
| P/B Ratio | 0.00 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 36.60 |  |
| Revenue | 46026000.00 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 652.34% | A |
| Profit Margin | -34.84% | E |
| Gross Margin | 40.39% | B |
| Revenue YoY | -7.44% | D |
| Net Profit YoY | 62.12% | B |
| Total Assets YoY | -29.69% | E |
| Net Assets YoY | -156.08% | E |
| Cash Flow Margin | 84.10% | C |
| OCF YoY | -7.44% | D |
| Turnover | 1.40 | A |
| Gearing Ratio | 112.11% | E |

```chart-data:radar
{
  "title": "Longbridge Financial Score - BIOLASE, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-7.44%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "62.12%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "0.00",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "36.60",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "46026000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "652.34%",
          "rating": "A"
        },
        {
          "name": "Profit Margin",
          "value": "-34.84%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "40.39%",
          "rating": "B"
        },
        {
          "name": "Revenue YoY",
          "value": "-7.44%",
          "rating": "D"
        },
        {
          "name": "Net Profit YoY",
          "value": "62.12%",
          "rating": "B"
        },
        {
          "name": "Total Assets YoY",
          "value": "-29.69%",
          "rating": "E"
        },
        {
          "name": "Net Assets YoY",
          "value": "-156.08%",
          "rating": "E"
        },
        {
          "name": "Cash Flow Margin",
          "value": "84.10%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "-7.44%",
          "rating": "D"
        },
        {
          "name": "Turnover",
          "value": "1.40",
          "rating": "A"
        },
        {
          "name": "Gearing Ratio",
          "value": "112.11%",
          "rating": "E"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 0.00 | 39/183 | - | - | - |
| PB | 0.00 | 140/183 | - | - | - |
| PS (TTM) | 0.00 | 1/183 | 0.00 | 0.00 | 0.00 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Delcath (DCTH.US) | C | A | B | A | A | A |
| 02 | Electromed (ELMD.US) | A | B | A | A | B | A |
| 03 | Intuitive Surgical (ISRG.US) | A | B | C | A | B | B |
| 04 | Stryker (SYK.US) | A | C | C | C | B | B |
| 05 | Boston Scientific (BSX.US) | A | B | C | C | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2024-10-06T04:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 1 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Highest Target | undefined |
| Lowest Target | undefined |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/BIOLQ.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/BIOLQ.US/norm.md)
- [Related News](https://longbridge.com/en/quote/BIOLQ.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/BIOLQ.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**